Sydney Vanhoose, ARNP

Sydney Vanhoose practices at Gardens Plastic Surgery in Cape Coral, Florida.

Sydney Vanhoose's NPI, 1386008373, was assigned on April 6, 2016. Sydney Vanhoose holds Florida license ARNP9429769.

Sydney Vanhoose's primary practice is Gardens Plastic Surgery, at 413 Del Prado S Blvd, Cape Coral, FL 33990 in Lee County. The practice phone is (239) 313-2515.

Sydney Vanhoose's primary practice is Gardens Plastic Surgery in Cape Coral, Florida. The medical group on file is AQUA Dermatology. Dmand AI also links Sydney Vanhoose to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sydney Vanhoose practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Sydney Vanhoose's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Sydney Vanhoose is licensed in Florida.

Dmand AI lists acne, acute skin infection, anxiety, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses and eyelid inflammation among the conditions Sydney Vanhoose treats.

CMS data shows 11,629 Medicare services from Sydney Vanhoose across 30 procedure codes in 2024, for 1,880 Medicare patients. Medicare paid $411,980 for them. Every service was in an office.

CMS counts 1,880 Medicare patients who saw Sydney Vanhoose in 2024. The largest group is 65 to 74, with 952 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Sydney Vanhoose's median patient age at 74, with 55% women.

In 2024, Sydney Vanhoose wrote 1,763 Medicare Part D claims for 922 patients. 92% of them were for generic drugs. CMS names the drug for 1,651 of them, across 24 drugs with 11 or more claims each, at $667,587 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Sydney Vanhoose for performance year 2024, reported as part of a group. Sydney Vanhoose accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 81 general payments to Sydney Vanhoose from 20 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 83% of the total. Janssen Pharmaceuticals, Inc paid the most, $550.